Retinal Degenerative Diseases

Robert E. Anderson

Editore: Springer Mrz 2014, 2014
ISBN 10: 1461432081 / ISBN 13: 9781461432081
Usato / Buch / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Neuware - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. 924 pp. Englisch. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
0 valutazione media
(0 valutazioni)

Riassunto:

This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012).  A majority of those who will speak and present posters at the meeting will contribute to this volume.  The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70.  The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them.  Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field.

 

The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.

 

While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010.  These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.

 

The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general.  It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS.  Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume.  We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Retinal Degenerative Diseases
Casa editrice: Springer Mrz 2014
Data di pubblicazione: 2014
Legatura: Buch
Condizione libro: Neu

I migliori risultati di ricerca su AbeBooks

1.

Ash, John D. et al. (Eds.):
Editore: New York, NY, Springer, 2014. (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Usato Rilegato Quantità: 1
Valutazione libreria
[?]

Descrizione libro New York, NY, Springer, 2014., 2014. Mechanisms and Experimental Therapy. Advances in Experimental Medicine and Biology, Vol. 801. LXI, 862 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Cover with bearing traces. Codice libro della libreria 30559AB

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra usato
EUR 125,00
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,96
Da: Germania a: U.S.A.
Destinazione, tempi e costi

2.

Editore: Springer-Verlag New York Inc., United States (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2014. Hardback. Condizione libro: New. 2014 ed.. Language: English . Brand New Book. This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the best and most important meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS.Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. Codice libro della libreria SPR9781461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 266,42
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

3.

John Ash
Editore: Springer New York 2014-03-25, New York (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 10
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer New York 2014-03-25, New York, 2014. hardback. Condizione libro: New. Codice libro della libreria 9781461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 266,43
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,35
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Editore: Springer-Verlag New York Inc., United States (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2014. Hardback. Condizione libro: New. 2014 ed.. Language: English . Brand New Book. This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the best and most important meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS.Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. Codice libro della libreria SPR9781461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 274,80
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Quantità: 1
Print on Demand
Da
BWB
(Valley Stream, NY, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Condizione libro: New. This item is Print on Demand - Depending on your location, this item may ship from the US or UK. Codice libro della libreria POD_9781461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 274,80
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

6.

Editore: Springer (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2014. Hardcover. Condizione libro: New. book. Codice libro della libreria 1461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 296,03
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

7.

Ash, John (Editor)/ Hollyfield, Joe G. (Editor)/ Lavail, Matthew M. (Editor)/ Anderson, Robert E. (Editor)/ Grimm, Christian (Editor)
Editore: Springer Verlag (2014)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 2
Da
Revaluation Books
(Exeter, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer Verlag, 2014. Hardcover. Condizione libro: Brand New. 2014 edition. 862 pages. 9.25x6.25x2.00 inches. In Stock. Codice libro della libreria __1461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 299,43
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,71
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Ash, John
Editore: Springer (2016)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2016. Paperback. Condizione libro: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice libro della libreria ria9781461432081_lsuk

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 308,34
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,33
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

9.

John Ash (Editor), Joe G. Hollyfield (Editor), Matthew M. LaVail (Editor), Robert E. Anderson (Editor), Christian Grimm (Editor), Catherine Bowes Rickman (Editor)
Editore: Springer (2013)
ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Rilegato Quantità: 1
Print on Demand
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2013. Hardcover. Condizione libro: New. 2013. This item is printed on demand. Codice libro della libreria SONG1461432081

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 306,03
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

10.

ISBN 10: 1461432081 ISBN 13: 9781461432081
Nuovi Quantità: 2
Da
BWB
(Valley Stream, NY, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Condizione libro: New. Depending on your location, this item may ship from the US or UK. Codice libro della libreria 97814614320810000000

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 309,61
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

Vedi altre 10 copie di questo libro

Vedi tutti i risultati per questo libro